Archive

Dive into a collection of past posts and rediscover timeless content.

The Often-Missed Corner of Healthcare That Wall Street Is Loving

Wall Street is quietly favoring lab-equipment and diagnostics firms — the "picks and shovels" of healthcare — after recent pullbacks left top names trading at discounts. Durable demand, new product launches and strategic deals could drive upside while offering lower volatility than high‐risk drug bets.

Mar 30, 2026

Is Oracle the First of the AI Bubbles to Pop?

A 60% selloff has turned Oracle from AI darling into a cautionary tale — but recent earnings beats and upbeat analyst notes hint the rout could be overdone. All eyes are on the next quarterly report to decide whether this is a true bubble pop or a reset-driven buying opportunity.

Mar 29, 2026

Quiet BNY Mellon and Northern Trust Reward Patient Investors

Stable, behind-the-scenes custodian banks are paying off for patient investors: BNY Mellon for growth and buybacks, Northern Trust for higher yield and steady performance. Both benefit from rising markets and higher rates — but could stumble if rates fall or markets weaken.

Mar 28, 2026

ASML’s $8B Deal: More Than a Purchase, It's a Prophecy

SK Hynix’s nearly $8 billion order confirms ASML as the indispensable architect of AI hardware, signalling a multi‐year surge in demand for EUV‐made memory. It underscores ASML’s monopoly on next‐gen lithography, durable pricing power and steady shareholder returns.

Mar 27, 2026

Microsoft’s Next AI Leg: Can MSFT Still Outperform From Here?

Trading near 52-week lows and cheap by historical standards, Microsoft faces hefty AI capex, OpenAI partnership uncertainty, and slow Copilot Pro adoption. Still, cash-rich fundamentals, bullish analyst targets, and oversold technicals leave room for a rebound if execution holds.

Mar 26, 2026

Macy’s Beats Expectations Again, But Guidance Spooks Investors

Macy’s delivered its fourth straight earnings beat, signaling traction for its “Bold New Chapter” turnaround. But conservative full-year guidance and tepid consumer-spending outlook prompted analysts to cut targets and sent the stock lower.

Mar 25, 2026

Active ETFs Surge Past Passive, and These Are in the Lead

Investors are flocking to actively managed ETFs as they hunt for alpha and portfolio flexibility. Standouts to watch: dividend-focused CGDV, GARP-oriented TCAF, and IVES — a passive fund that behaves like an active play.

Mar 24, 2026

Planet Labs: The Satellite Stock That Keeps Shooting to the Moon

Fueled by blowout earnings, AI-driven demand and a $900 million backlog, Planet Labs has posted meteoric gains. Still, its lofty valuation hinges on sustained commercial growth and profitability.

Mar 23, 2026

The S&P 500 Broke Its 200-Day Moving Average—Here's What to Expect

The slip below the 200‐day is a classic inflection point — it can either reverse into a fresh rally or precede a deeper correction. With volatility and geopolitical risks rising, the next few sessions will determine whether this is a shakeout or something more serious.

Mar 22, 2026

Expedia Stock Turns Volatile After Rally. Where Does It Go Next?

After a yearlong surge and a post‐earnings pullback, Expedia’s solid fundamentals and analyst upside clash with margin worries, rising short interest and macro risks. The result: clear upside potential but likely continued volatility.

Mar 21, 2026

Forget Chipmakers: Walmart and Target Are the Real AI Plays

How Walmart and Target use AI to cut costs, speed fulfillment and boost dividends — a steadier way to play the AI boom.

Mar 20, 2026

Why Credo and Astera Soared After Oracle and Broadcom's Earnings

Oracle’s data-center buildout and Broadcom’s warning that copper will stay relevant in scale-up AI servers sent Credo and Astera higher. The moves highlight rising demand for copper-based connectivity in AI infrastructure — but customer concentration remains a key risk.

Mar 19, 2026